What are the guideline sources, guidelines and references for Acute otitis externa ?
Guideline sources The following summarized guidelines for the evaluation and management of acute otitis externa are prepared by our editorial team based on guidelines from the Infectious Diseases Society of America (IDSA 2016) and the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF 2014). 1 2 Guidelines 1. Diagnostic investigations Assessment: Distinguish diffuse acute otitis externa from other causes of otalgia, otorrhea, and inflammation of the external ear canal. B Assess the patient with diffuse acute otitis externa for factors that modify management (nonintact tympanic membrane, tympanostomy tube, diabetes, immunocompromised state, prior radiotherapy). B 2. Medical management Systemic antibiotics: do not offer systemic antimicrobials as initial therapy for diffuse, uncomplicated acute otitis externa unless there is extension outside the ear canal or the presence https://web.pathway.md/diseases/recKDAkqHsIVEC2Ux 1/3 6/23/23, 2:01 AM Acute otitis externa Pathway of specific host factors that would indicate a need for systemic therapy. D Topical therapy: prescribe topical preparations for initial therapy of diffuse, uncomplicated acute otitis externa. B Show 2 more Updated evidence: Ototopical ABX and CS in AOE (ciprofloxacin plus fluocinolone vs. ciprofloxacin) In adults and children aged > 6 months with acute otitis externa, ciprofloxacin plus fluocinolone acetonide was not superior to ciprofloxacin alone with respect to clinical and microbiological cure at day 8-10. Laurence Chu et al. JAMA Netw Open. 2022 Jul 1. Pain management: assess patients with acute otitis externa for pain and prescribe analgesics based on the severity of pain. B 3. Specific circumstances Patients with Aspergillus otitis externa: perform mechanical cleansing of the external auditory canal and administer topical antifungals or boric acid in patients with non-invasive Aspergillus otitis externa. B 4. Follow-up and surveillance Follow-up: reassess the patient who fails to respond to the initial therapeutic option within 48 to 72 hours to confirm the diagnosis of diffuse acute otitis externa and to exclude other causes of illness. B References 1. Richard M. Rosenfeld, MD, MPH et al. Clinical Practice Guideline: Acute Otitis Externa. 2014 Feb;150 1 Suppl):S1 S24. Open 2. Patterson TF, Thompson GR rd, Denning DW et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Aug 15;63 4):e1-e60. Open 3. Rosenfeld RM, Schwartz SR, Cannon CR et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150 1 Suppl):S1 S24. Open 4. Laurence Chu, Ana M Acosta, Hessam Aazami et al. Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial. JAMA Netw Open. 2022 Jul 1;5 7):e2221699. Open https://web.pathway.md/diseases/recKDAkqHsIVEC2Ux 2/3 6/23/23, 2:01 AM Acute otitis externa Pathway https://web.pathway.md/diseases/recKDAkqHsIVEC2Ux 3/3